Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 356

1.

Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.

Cecchinato V, Bernasconi E, Speck RF, Proietti M, Sauermann U, D'Agostino G, Danelon G, Rezzonico Jost T, Grassi F, Raeli L, Schöni-Affolter F, Stahl-Hennig C, Uguccioni M; Swiss HIV Cohort Study..

J Immunol. 2016 Nov 28. pii: 1600568. [Epub ahead of print]

PMID:
27895171
2.

MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.

Huber M, Metzner KJ, Geissberger FD, Shah C, Leemann C, Klimkait T, Böni J, Trkola A, Zagordi O.

J Virol Methods. 2016 Nov 17;240:7-13. doi: 10.1016/j.jviromet.2016.11.008. [Epub ahead of print]

3.

Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1.

Bader J, Däumer M, Schöni-Affolter F, Böni J, Gorgievski-Hrisoho M, Martinetti G, Thielen A, Klimkait T; Swiss HIV Cohort Study..

Clin Infect Dis. 2016 Nov 12. pii: ciw737. [Epub ahead of print]

PMID:
27838645
4.

Determinants of HIV-1 broadly neutralizing antibody induction.

Rusert P, Kouyos RD, Kadelka C, Ebner H, Schanz M, Huber M, Braun DL, Hozé N, Scherrer A, Magnus C, Weber J, Uhr T, Cippa V, Thorball CW, Kuster H, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Fellay J, Regoes RR, Günthard HF, Trkola A; Swiss HIV Cohort Study..

Nat Med. 2016 Nov;22(11):1260-1267. doi: 10.1038/nm.4187.

PMID:
27668936
5.

A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.

Ragonnet-Cronin ML, Shilaih M, Günthard HF, Hodcroft EB, Böni J, Fearnhill E, Dunn D, Yerly S, Klimkait T, Aubert V, Yang WL, Brown AE, Lycett SJ, Kouyos R, Brown AJ.

Sci Rep. 2016 Sep 19;6:32251. doi: 10.1038/srep32251.

6.

Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.

Oberle CS, Joos B, Rusert P, Campbell NK, Beauparlant D, Kuster H, Weber J, Schenkel CD, Scherrer AU, Magnus C, Kouyos R, Rieder P, Niederöst B, Braun DL, Pavlovic J, Böni J, Yerly S, Klimkait T, Aubert V, Trkola A, Metzner KJ, Günthard HF; Swiss HIV Cohort Study (SHCS)..

Retrovirology. 2016 Sep 5;13(1):62. doi: 10.1186/s12977-016-0299-0.

7.

Large-scale inference of conjunctive Bayesian networks.

Montazeri H, Kuipers J, Kouyos R, Böni J, Yerly S, Klimkait T, Aubert V, Günthard HF, Beerenwinkel N; Swiss HIV Cohort Study..

Bioinformatics. 2016 Sep 1;32(17):i727-i735. doi: 10.1093/bioinformatics/btw459.

PMID:
27587695
8.

A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin.

Luu KT, Boni J.

Cancer Chemother Pharmacol. 2016 Oct;78(4):697-708. doi: 10.1007/s00280-016-3118-3.

PMID:
27491482
9.

Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2.

Zbinden A, Dürig R, Shah C, Böni J, Schüpbach J.

PLoS One. 2016 Jun 16;11(6):e0157690. doi: 10.1371/journal.pone.0157690.

10.

Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.

Shilaih M, Marzel A, Yang WL, Scherrer AU, Schüpbach J, Böni J, Yerly S, Hirsch HH, Aubert V, Cavassini M, Klimkait T, Vernazza PL, Bernasconi E, Furrer H, Günthard HF, Kouyos R; Swiss HIV Cohort Study..

Sci Rep. 2016 Jun 14;6:27580. doi: 10.1038/srep27580.

11.

Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin.

Betts AM, Haddish-Berhane N, Tolsma J, Jasper P, King LE, Sun Y, Chakrapani S, Shor B, Boni J, Johnson TR.

AAPS J. 2016 Sep;18(5):1101-16. doi: 10.1208/s12248-016-9929-7.

PMID:
27198897
12.

Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.

Shilaih M, Marzel A, Scherrer AU, Braun DL, Kovari H, Rougemont M, Darling K, Battegay M, Hoffmann M, Bernasconi E, Hirzel C, Günthard HF, Kouyos RD; Swiss HIV Cohort Study a.; Swiss HIV Cohort Study..

J Infect Dis. 2016 Aug 15;214(4):599-606. doi: 10.1093/infdis/jiw195.

PMID:
27190182
13.

Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma.

Ogura M, Tobinai K, Hatake K, Davies A, Crump M, Ananthakrishnan R, Ishibashi T, Paccagnella ML, Boni J, Vandendries E, MacDonald D.

Clin Cancer Res. 2016 Oct 1;22(19):4807-4816.

PMID:
27154915
14.

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

Scherrer AU, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Hauser C, Calmy A, Schmid P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study..

J Infect Dis. 2016 Aug 1;214(3):399-402. doi: 10.1093/infdis/jiw165.

PMID:
27130429
15.

HIV-Positive-to-HIV-Positive Liver Transplantation.

Calmy A, van Delden C, Giostra E, Junet C, Rubbia Brandt L, Yerly S, Chave JP, Samer C, Elkrief L, Vionnet J, Berney T; Swiss HIV and Swiss Transplant Cohort Studies..

Am J Transplant. 2016 Aug;16(8):2473-8. doi: 10.1111/ajt.13824.

PMID:
27109874
16.

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Barceló C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study..

J Antimicrob Chemother. 2016 Jul;71(7):1933-42. doi: 10.1093/jac/dkw050.

PMID:
27029846
17.

Correlating HIV tropism with immunological response under combination antiretroviral therapy.

Bader J, Schöni-Affolter F, Böni J, Gorgievski-Hrisoho M, Martinetti G, Battegay M, Klimkait T; Swiss HIV Cohort Study..

HIV Med. 2016 Sep;17(8):615-22. doi: 10.1111/hiv.12365.

PMID:
26991140
18.

Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.

Scherrer AU, von Wyl V, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Furrer H, Calmy A, Vernazza P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study.; Swiss HIV Cohort Study..

Clin Infect Dis. 2016 May 15;62(10):1310-7. doi: 10.1093/cid/ciw128.

PMID:
26962075
19.

Study of breast cancer incidence in patients of lymphangioleiomyomatosis.

Nuñez O, Román A, Johnson SR, Inoue Y, Hirose M, Casanova Á, de Garibay GR, Herranz C, Bueno-Moreno G, Boni J, Mateo F, Petit A, Climent F, Soler T, Vidal A, Sánchez-Mut JV, Esteller M, López JI, García N, Gumà A, Ortega R, Plà MJ, Campos M, Ansótegui E, Molina-Molina M, Valenzuela C, Ussetti P, Laporta R, Ancochea J, Xaubet A, Pollán M, Pujana MA.

Breast Cancer Res Treat. 2016 Feb;156(1):195-201. doi: 10.1007/s10549-016-3737-8.

20.

Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.

Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord..

Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0.

PMID:
26939735
Items per page

Supplemental Content

Loading ...
Support Center